News from apexigen, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Apr 09, 2021, 08:00 ET Apexigen Announces Presentations Of Preclinical Data For Its TNFR2 Antagonist (APX601) And SIRPα Antagonist (APX701) Programs At The AACR Annual Meeting 2021

Apexigen, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of antibody therapeutics for...

Mar 01, 2021, 07:00 ET Apexigen to Present at Investor Conferences in March and April 2021

Apexigen, Inc., a clinical-stage biopharmaceutical company, today announced that Xiaodong Yang, M.D., Ph.D., President and Chief Executive Officer,...

Jan 07, 2021, 20:08 ET Apexigen to Present at Virtual Investor Conferences

Apexigen, Inc., a clinical-stage biopharmaceutical company, today announced that Xiaodong Yang, M.D., Ph.D., President and Chief Executive Officer,...

Nov 09, 2020, 07:00 ET Apexigen Announces First Preclinical Data Presentations On Novel Anti-TNFR2 And Anti-SIRPα Antibody Programs At The 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Apexigen, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of antibody therapeutics for...

Oct 15, 2020, 07:00 ET Apexigen's APX005M Granted Orphan Drug Designations for the Treatment of Esophageal and Gastroesophageal Junction Cancer and for the Treatment of Pancreatic Cancer

Apexigen, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of antibody therapeutics for...

Oct 13, 2020, 07:00 ET Apexigen to Present at Solebury Trout Fall 2020 Virtual Private Company Showcase

Apexigen, Inc., a clinical-stage biopharmaceutical company, today announced that Xiaodong Yang, M.D., Ph.D., President and Chief Executive Officer,...

Aug 19, 2020, 07:00 ET Apexigen Appoints Jakob Dupont to Board of Directors

Apexigen, Inc. announced today the appointment of Jakob Dupont, M.D., to its Board of Directors. Dr. Dupont joins Apexigen's Board of Directors with...

Jun 04, 2020, 07:00 ET Apexigen Appoints Gordon Ringold to its Board of Directors

Apexigen, Inc. announced today the appointment of Gordon Ringold, Ph.D., to its Board of Directors. Dr. Ringold joins Apexigen's Board of Directors...

Mar 26, 2020, 07:00 ET Apexigen To Present At The Upcoming 2020 Solebury Trout Virtual Investor Conference

Apexigen, Inc., a clinical-stage biopharmaceutical company, today announced that Xiaodong Yang, M.D., Ph.D., President and Chief Executive Officer,...

Mar 24, 2020, 07:00 ET Apexigen Completes $123 Million Series C Financing To Advance Clinical Pipeline

Apexigen, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of antibody therapeutics for...

Feb 27, 2020, 07:00 ET Apexigen To Present At Upcoming Investor Conferences

Apexigen, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of antibody therapeutics for...

Dec 06, 2019, 07:00 ET Apexigen Expands Leadership Team with Two Key Appointments in CMC and Clinical Development

Apexigen, Inc. announced today the appointments of Jason Wright, Ph.D., as Vice President, CMC and Thomas Jahn, M.D., Ph.D., as Vice President,...

Oct 16, 2019, 08:00 ET Apexigen's CEO, Xiaodong Yang, Recognized Among 100 Most Intriguing Entrepreneurs at Goldman Sachs 2019 Builders + Innovators Summit

Apexigen, Inc. announced today that Goldman Sachs is recognizing its founder and CEO, Xiaodong Yang, as one of the 100 Most Intriguing Entrepreneurs...

Oct 16, 2019, 08:00 ET Apexigen to Present at the 2019 Solebury Trout Private Company Showcase

Apexigen, Inc. announced today that Xiaodong Yang, M.D., Ph.D., President & Chief Executive Officer, will present at the upcoming Solebury Trout...

Oct 09, 2019, 07:00 ET Apexigen Appoints Biotechnology Financial Executive Herb Cross to Board of Directors

Apexigen, Inc. announced today that Herb C. Cross has joined its Board of Directors as an independent director. Mr. Cross joins Apexigen's Board of...

Sep 24, 2019, 07:00 ET Apexigen Announces Participation In Upcoming Oncology Conferences

Apexigen, Inc. today announced its participation at the following upcoming oncology-focused conferences to discuss the role of the CD40 pathway in...

Sep 04, 2019, 07:00 ET Apexigen Appoints Scott Smith to Board of Directors

Apexigen, Inc. announced today the appointment of Scott Smith to its Board of Directors. Mr. Smith joins Apexigen's Board of Directors with over 30...

Apr 01, 2019, 13:00 ET Apexigen Presents Clinical Data On CD40 Antibody APX005M In Metastatic Melanoma At The AACR Annual Meeting 2019

Apexigen, Inc., a clinical-stage biopharmaceutical company, today presented new clinical data on APX005M at the American Association for Cancer...

Mar 31, 2019, 12:50 ET Apexigen Announces New Clinical Data On APX005M In Combination Therapy For Pancreatic Cancer At The AACR Annual Meeting 2019

Apexigen, Inc., a clinical-stage biopharmaceutical company, today announced the presentation of new clinical data on APX005M in combination therapy...

Mar 20, 2019, 06:00 ET Apexigen Announces Clinical Data Presentations On CD40 Antibody APX005M At The AACR Annual Meeting 2019

Apexigen, Inc., a clinical-stage biopharmaceutical company, today announced new clinical data on APX005M will be presented at the American...

Feb 19, 2019, 06:00 ET Apexigen To Present At Upcoming Investor Conferences

Apexigen, Inc., a clinical-stage biopharmaceutical company, today announced that Xiaodong Yang, M.D., Ph.D., President and Chief Executive Officer,...

Dec 20, 2018, 06:00 ET Apexigen Announces Clinical Collaboration On A New Phase 2 Trial For APX005M In Sarcoma

Apexigen, Inc., a clinical-stage biopharmaceutical company, today announced a collaboration with Columbia University Irving Medical Center on a new...

Nov 26, 2018, 20:00 ET Apexigen To Present At Piper Jaffray's 30th Annual Healthcare Conference

Apexigen, Inc., a clinical-stage biopharmaceutical company, today announced that Xiaodong Yang, M.D., Ph.D., President and Chief Executive Officer,...

Aug 08, 2018, 06:00 ET Apexigen Raises $73 Million In Series B And Series C Financings

Apexigen, Inc., a clinical-stage biopharmaceutical company, today announced the successful completion of its Series B and Series C financings in...

Jun 14, 2018, 07:00 ET Apexigen and Yale Cancer Center Announce Clinical Collaboration to Evaluate APX005M, Cabiralizumab, and Opdivo (Nivolumab) in Patients whose Disease has Progressed on Anti-PD-1/PD-L1 Therapy

Apexigen, Inc., and Yale Cancer Center today announced a clinical trial collaboration to evaluate Apexigen's APX005M in combination with...